Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial
Titel:
Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial
Auteur:
Hurvitz, S.A. Quek, R.G.W. Turner, N.C. Telli, M.L. Rugo, H.S. Mailliez, A. Ettl, J. Grischke, E. Mina, L.A. BalmaƱa, J. Fasching, P.A. Bhattacharyya, H. Hannah, A.L. Robson, M.E. Wardley, A.M.